Back to top
more

Humana (HUM)

(Delayed Data from NYSE)

$279.45 USD

279.45
7,041,273

-37.29 (-11.77%)

Updated Oct 1, 2024 04:00 PM ET

After-Market: $278.50 -0.95 (-0.34%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 8% (232 out of 251)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Can Enrollment Growth Drive Anthem (ANTM) in Q3 Earnings?

by Zacks Equity Research

Anthem's (ANTM) third-quarter results are likely to be aided by membership growth.

    Will CNC Q3 Earnings Come in Better Than ESRX on Oct 24?

    by Zacks Equity Research

    Centene (CNC) is expected to post better results in Q3 compared to Express Scripts (ESRX) on the back of solid revenue growth driven by rising membership.

      Can Medicaid Business Drive Centene's (CNC) Q3 Earnings?

      by Zacks Equity Research

      Centene's (CNC) third-quarter results are expected to be positively impacted by its Medicaid expansion initiatives.

        Humana Expands MA Offerings, Increases Benefits for Members

        by Zacks Equity Research

        Humana (HUM) continues to expand and restructure its Medicare Advantage plans in order to enhance the reach and quality of its offerings across the world.

          UnitedHealth (UNH) Beats Q3 Earnings on Higher Membership

          by Zacks Equity Research

          UnitedHealth (UNH) beats earnings in the third quarter driven by higher contribution from both its segments.

            WellCare (WCG) Unit Receives Favorable Star Ratings From CMS

            by Zacks Equity Research

            WellCare's (WCG) efforts to boost its Medicare business and provide its Medicare Advantage members quality services have helped it achieve favorable Star Quality ratings from CMS

              Will Quest Diagnostics (DGX) Disappoint in Q3 Earnings?

              by Zacks Equity Research

              The overall soft industry trends leading to low volume environment may continue to put a dampener on Quest Diagnostics (DGX) in Q3. The reimbursement scenario also remains a major cause for concern.

                Buy These 4 Momentum Stocks for Exciting Returns

                by Zacks Equity Research

                This screen will help you to get into momentum stocks that are storming ahead. Highlighted stocks include HUM, JBL, GBX and AMTD.

                  Anthem (ANTM) & Units Receive Medicare Star Ratings From CMS

                  by Zacks Equity Research

                  Anthem's (ANTM) focus on improving the quality of healthcare for its Medicare Advantage members has enabled it achieve favorable Star Ratings from CMS

                    UnitedHealth (UNH) Q3 Earnings Likely to Beat: Here's Why?

                    by Zacks Equity Research

                    UnitedHealth's (UNH) third-quarter earnings are expected to benefit from strong contribution from both its segments along earnings accretion from disciplined capital management.

                      Molina Healthcare Appoints CEO: Will New Leadership Help?

                      by Zacks Equity Research

                      Molina Healthcare (MOH) appoints new CEO in an attempt to regain its lost glory.

                        WellCare Health Grows on Revenues, Debt Level Hurts

                        by Zacks Equity Research

                        Wellcare Health's (WCG) revenues continue to grow on the back of several organic and inorganic growth strategies. However, rising level of debt and expenses keep draining the bottom line.

                          Humana Partners With Community Care, Improves Healthcare

                          by Zacks Equity Research

                          Humana (HUM) builds strategic alliances in order to expand its geographical presence and ensure premium quality of healthcare by strengthening its value proposition.

                            Anthem Grows on Membership, Public Exchange Woes Hurt

                            by Zacks Equity Research

                            Although Anthem's (ANTM) revenue base continues to strengthen on the back of growing membership. Losses incurred in the public exchange business bother.

                              Public Exchange Woes Hit Health Insurers: Stocks in Focus

                              by Zacks Equity Research

                              The U.S private health insurers have been incurring mounting losses from the health insurance marketplace. This has led many of them to pull back participation, worsening the scenario for underprivileged Americans.

                                3 Value Stocks in Health Insurance to Bet On

                                by Zacks Equity Research

                                The Health Insurance industry gains from growing government business, benefits of ACA, business diversification and profit-boosting medical plans despite regulatory hurdles

                                  Humana (HUM) Up 6.4% Since Earnings Report: Can It Continue?

                                  by Zacks Equity Research

                                  Humana (HUM) reported earnings more than a month ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                    Humana (HUM) Hits 52-Week High on Solid Q2, Raised Outlook

                                    by Zacks Equity Research

                                    Humana's (HUM) shares have been favored by its strong earnings performance, guidance raise and completion of accelerated share buyback.

                                      Wellcare Health's (WCG) Inorganic Growth Boosts Revenues

                                      by Zacks Equity Research

                                      Wellcare Health's (WCG) solid top line grows on strategic acquisitions and alliances. Its strong financial health also bodes well for long-term growth.

                                        Aetna's (AET) $1 Billion Notes Due 2047 Rated By A.M Best

                                        by Zacks Equity Research

                                        Rating Giant A.M Bests assigned a Long-Term Issue Credit Rating of "bbb" to Aetna's (AET) $1 billion, 3.875% senior notes due to mature on Aug 15, 2047.

                                          Envision Healthcare (EVHC) Q2 Earnings Beat, '17 View Cut

                                          by Zacks Equity Research

                                          Envision Healthcare's (EVHC) strong second-quarter earnings were driven by revenue growth in the Physician Services segment, partly offset by an increase in operating expenses.

                                            Select Medical (SEM) Q2 Earnings Top Estimates, Revises View

                                            by Zacks Equity Research

                                            Select Medical's (SEM) solid Q2 results were driven by the strong performance of all segments.

                                              Tenet Healthcare's (THC) Q2 Loss In Line with Estimates

                                              by Zacks Equity Research

                                              Tenet Healthcare (THC) incurred net loss in second-quarter 2017 owing to lower revenue generation.

                                                Cigna (CI) Earnings Beat in Q2, Guidance Raised, Shares Gain

                                                by Zacks Equity Research

                                                Higher revenues, strength in its Global HealthCare segment and membership growth drive an earnings beat at Cigna (CI) in Q2.

                                                  The Ensign Group (ENSG) Q2 Earnings Miss Estimates, Up Y/Y

                                                  by Zacks Equity Research

                                                  The Ensign Group's (ENSG) second-quarter earnings missed expectations owing to higher expenses.